Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methylnaltrexone Versus Naloxegol in the Treatment of Opioid-Induced Constipation in the Emergency Department

NCT03523520 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT03523520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03523520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methylnaltrexone Versus Naloxegol in the Treatment of Opioid-Induced Constipation in the Emergency Department
Lead sponsor
University of Missouri-Columbia
Phase
Phase 4
Overall status
Completed
Start date
December 23, 2020
Completion date
March 31, 2023
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

constipation drug induced